Current concepts in the treatment of hereditary ataxias

Pedro Braga Neto1, José Luiz Pedroso2, Sheng-Han Kuo3

  • 1Center of Health Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil.

Insights

Hereditary ataxias (HA) are neurodegenerative diseases with no cure, requiring symptomatic management. This review covers treatments for various HA types, focusing on symptom relief and future therapeutic strategies.

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Background:

  • Hereditary ataxias (HA) are a diverse group of neurodegenerative disorders.
  • Characterized by progressive ataxia and multi-systemic symptoms.
  • Currently, no definitive cure exists, with management focused on symptom relief.

Purpose of the Study:

  • To review symptomatic treatments for major types of hereditary ataxias.
  • To explore mechanism-based approaches and rehabilitation therapies.
  • To discuss future clinical trials, genetic counseling, and preimplantation genetic diagnosis.

Main Methods:

  • Literature review focusing on symptomatic management of hereditary ataxias.
  • Analysis of treatment strategies for autosomal recessive, autosomal dominant, X-linked, and mitochondrial ataxias.
  • Synthesis of information on rehabilitation, disease-modifying therapies, and genetic diagnostics.

Main Results:

  • Detailed management strategies for diverse clinical symptoms associated with HA.
  • Overview of current and emerging therapeutic approaches.
  • Discussion on the role of genetic counseling and diagnostics in managing HA.

Conclusions:

  • Symptomatic treatment and supportive care are crucial for managing hereditary ataxias.
  • A multi-faceted approach including rehabilitation and genetic insights is essential.
  • Ongoing research and clinical trials offer hope for future disease-modifying therapies.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
10.0K